Cargando…

Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma

BACKGROUND: Alpha‐fetoprotein (AFP), routinely used for diagnosis of hepatocellular carcinoma (HCC), is limited with relatively low sensitivity and high false positivity in HBV‐related HCC (HBV‐HCC). Thus, an alternative approach was explored to improve specificity/sensitivity for diagnosis of HBV‐H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yezhou, Liu, Kehui, Xu, Yumin, Zhao, Qingqing, Lou, Shike, Xiang, Xiaogang, Yan, Lei, Cao, Zhujun, Xie, Qing, Zhu, Chuanwu, Bao, Shisan, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196063/ https://www.ncbi.nlm.nih.gov/pubmed/32150664 http://dx.doi.org/10.1002/cam4.2968

Ejemplares similares

Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma
por: Liu, Kehui, et al.
Publicado: (2022)

Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome
por: Chen, Liwen, et al.
Publicado: (2020)

Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Qingqing, et al.
Publicado: (2020)

Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
por: Yan, Lei, et al.
Publicado: (2018)

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
por: Lou, Shike, et al.
Publicado: (2023)

The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China
por: Ding, Yezhou, et al.
Publicado: (2023)

Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2017)

AL amyloidosis with primary presentation of multiple serous cavity effusion and severe cholestasis: a case report and review of literature
por: Liu, Kehui, et al.
Publicado: (2022)

Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
por: Nguyen, Hoang Bac, et al.
Publicado: (2022)

Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng–Tongji cohort study
por: Wang, Ke, et al.
Publicado: (2018)

Identification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screening
por: Wang, Hui, et al.
Publicado: (2015)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure
por: Cao, Zhujun, et al.
Publicado: (2015)

Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation
por: Si, Yuan-Quan, et al.
Publicado: (2020)

Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients
por: Chen, Liwen, et al.
Publicado: (2018)

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
por: Ge, Zijun, et al.
Publicado: (2019)

Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis
por: Liu, Siyu, et al.
Publicado: (2022)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma
por: Vongsuvanh, Roslyn, et al.
Publicado: (2016)

Diagnostic accuracy of LAMP assay for HBV infection
por: Chen, Chu‐Mao, et al.
Publicado: (2020)

The diagnostic performance of AFP and PIVKA-II models for non-B non-C hepatocellular carcinoma
por: Tran, Vinh Thanh, et al.
Publicado: (2023)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

PLCE1 polymorphisms and expression combined with serum AFP level predicts survival of HBV-related hepatocellular carcinoma patients after hepatectomy
por: Liao, Xiwen, et al.
Publicado: (2017)

TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma
por: Mao, Liping, et al.
Publicado: (2017)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha‐fetoprotein assessment
por: Tajiri, Hitoshi, et al.
Publicado: (2016)

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
por: Xu, Fei, et al.
Publicado: (2021)

Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
por: Wang, Xueying, et al.
Publicado: (2020)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients
por: Liu, Kehui, et al.
Publicado: (2016)

AFP
Publicado: (2009)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
por: Liu, Ruoyu, et al.
Publicado: (2021)

Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2020)

PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients
por: Suttichaimongkol, Tanita, et al.
Publicado: (2023)

Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma
por: Mao, Minjie, et al.
Publicado: (2020)

Improved affinity AFP-specific T cell receptor for hepatocellular carcinoma
por: Gerry, Andrew B, et al.
Publicado: (2013)

The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma
por: Huang, Yu-Liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f0ofpp7fie1erlt1556mjlt8kd